Another Samsung Bioepis? Biocon, Viatris mull merging biosimilar businesses: report aliu Thu, 12/09/2021 – 10:59 More: Another Samsung Bioepis? Biocon, Viatris mull merging biosimilar businesses: report Source: fierce
read moreAmid Aduhelm’s rocky launch, Biogen eyes large-scale layoffs: report fkansteiner Thu, 12/09/2021 – 10:58 More: Amid Aduhelm's rocky launch, Biogen eyes large-scale layoffs: report Source: fierce
read moreBioPure set to add 120 jobs at newly completed UK manufacturing site jkeenan Thu, 12/09/2021 – 10:28 More: BioPure set to add 120 jobs at newly completed UK manufacturing site Source: fierce
read moreAmid consumer spinoff and CEO transition, Johnson & Johnson names new leadership team kdunleavy Thu, 12/09/2021 – 10:05 More: Amid consumer spinoff and CEO transition, Johnson & Johnson names new leadership team Source: fierce
read moreShanghai Pharma, Syntegon to build lab in China to advance continuous manufacturing tech jkeenan Thu, 12/09/2021 – 09:47 More: Shanghai Pharma, Syntegon to build lab in China to advance continuous manufacturing tech Source: fierce
read moreThe drug is additionally undergoing assessment with the Medicines and Healthcare products Regulatory Agency for a marketing authorisation in the UK More: NICE publish final guidance recommending Aspaveli in adults with ultra-rare blood disorder Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals